Hims & Hers stock just fell 16.5% to about US$19 in regular trading, wiping out a chunk of short term gains after Q3 2026 results hit the tape. The selloff lands on a quarter where revenue reached US$890.4m and the business generated US$82m of adjusted earnings before interest, tax, depreciation and amortisation, even as it still reported a US$33m loss. Traders are reacting to the profit squeeze and guidance reset. Longer term investors are now weighing a fast growing digital health platform...
SAN JOSE, Kalifornien--(BUSINESS WIRE)--NetApp® (NASDAQ: NTAP), das Unternehmen für intelligente Dateninfrastruktur, gab heute bekannt, dass Nebul, ein europäischer Anbieter von KI-nativen Cloud-Lösungen, als erster Neocloud-Anbieter NetApp Novus™ einsetzt – die neue Hochleistungsarchitektur des Unternehmens, die den schnellsten Speicher der Welt bereitstellt. Nebul baut die „Intelligent Cloud“ auf, eine souveräne Plattform, die beschleunigte Infrastruktur, Unternehmensdatendienste und produkti
Gold edged higher, recouping some losses triggered by a high US inflation print and hawkish remarks from Federal Reserve officials that reinforced expectations of a December rate hike.
Cyprium Metals Ltd (ASX:CYM, OTCQB:CYPMF) has opened a share purchase plan (SPP) targeting approximately A$5 million, which will add to the company’s...
GE Vernovas backlog is large and supports predictable future revenue. However, there is a range of outcomes for its future valuation based on the sustainability of order flows through 2030.
archTIS Ltd (ASX:AR9, OTCQB:ARHLF) has secured an A$217,000 contract with a Nasdaq-listed US satellite communications and defence technology company,...
Shares of Hims & Hers Health (HIMS) continued to slide in after-hours trading on Tuesday as the telehealth provider faced fresh regulatory pressure on top of a disappointing earnings report released the day before.The Federal Trade Commission on Tuesday filed an amended complaint in the U.S. Distri…
The Federal Trade Commission on Tuesday filed an amended complaint in the U.S. District Court for the Northern District of California, adding Arizona, Florida, Nebraska, Ohio, and Wisconsin as co-plaintiffs.
Stellus Capital Investment Corp (SCM) reported Q3 2026 core NII of $0.26 per share and expects to cover its $0.25 dividend despite a 3% NAV decline driven by portfolio write-downs.
Sunrise Realty Trust, Inc. (SUNS) delivered earnings and revenue surprises of -17.24% and -4.17%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Although the revenue and EPS for Mercury Systems (MRCY) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Netceed, ein weltweit führender Anbieter von Lieferkettenlösungen für Breitband-, Rechenzentrums- und Energieinfrastrukturen, gab heute die Ernennung von Eric Updyke zum Group CEO mit Wirkung zum 10. November 2026 bekannt. Er tritt die Nachfolge von Alper Turken an, der am 10. November 2026 als CEO zurücktreten wird. Eric Updyke verfügt über mehr als 35 Jahre Führungserfahrung in den Bereichen Kommunikations- und Technologieinfrastruktur. Zuletzt war er vo
The 2025 tax law is still unfolding, and 18 of its changes show up for the first time on 2026 returns. Meredith Margrave explains whats new, who it affects, and what to do before December 31.
SATELLOGIC INC (SATL) delivered earnings and revenue surprises of -200.00% and +14.46%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of +25.00% and -17.27%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Marchex (MCHX) delivered earnings and revenue surprises of 0.00% and -1.64%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Sky Harbour Group (SKYH) delivered earnings and revenue surprises of 0.00% and +1.21%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Meren Energy (MRNFF) delivered earnings and revenue surprises of 0.00% and +52.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
ICL Group (ICL) delivered earnings and revenue surprises of -9.09% and -10.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Anterix (ATEX) delivered earnings and revenue surprises of +44.44% and -0.05%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Fold Holdings, Inc. (FLD) delivered earnings and revenue surprises of -10.00% and -48.69%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Fossil Group (FOSL) delivered earnings and revenue surprises of +533.33% and +9.71%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
GrowGeneration (GRWG) delivered earnings and revenue surprises of -100.00% and -0.28%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Nvidia shares extended their sell-off as an investigation involving CEO Jensen Huang raised fresh concerns about corporate governance, leadership uncertainty, and the AI chipmakers future.
Graco has entered into an accelerated share repurchase agreement to buyback company shares worth $600 million, it said Tuesday. Under the agreement, Graco will pay $600 million upfront and expects to...
Global stocks climbed as investor enthusiasm for the artificial intelligence trade outweighed concern that hotter-than-expected US inflation will prompt the Federal Reserve to raise interest rates further. Bonds slumped.
Although the revenue and EPS for Black Rock Coffee Bar, Inc. (BRCB) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
While the top- and bottom-line numbers for Angel Studios, Inc. (ANGX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The S&P/ASX Small Ordinaries (XSO) jumped 73.9 points, or 2.29%, to 3,305.0 yesterday, extending its strong recent run and taking its five-day gain to 161.7...
We just published a list of the 10 Stocks Analysts Just Downgraded and Nvidia (NASDAQ:NVDA) ranked 10th on this list. Wall Street has had a rough start to November. The Nasdaq Composite fell 5.52% on November 5, its steepest one-day drop in 19 months, and slid into a correction, more than 10% below its October […]
Space Exploration Technologies stock price could be noticeably higher by this time next year, but successful investing requires thinking about the long term.
Das Goldene Lenkrad feiert sein 50. Jubiläum mit 17 Preisträgern in 15 Kategorien. Kia erhält drei Auszeichnungen, darunter für den K4 Sportswagon und den EV2.
The telehealth company also announced that Andrew Huberman will join its board. The appointment comes as the business faces questions about consumer trust.
Überraschend stark gestiegene Verbraucherpreise drücken auf die Stimmung an der Wall Street. Die US-Anleger befürchten inzwischen eine Zinserhöhung im Dezember, was die KI-Investitionen der Techriesen verteuern dürfte. Nvidia muss erneut Federn lassen.
National Health Investors (NYSE:NHI) reduced its full-year distribution guidance after its senior housing operating portfolio fell short of third-quarter expectations, even as the company continued shifting capital from skilled nursing into senior housing. Chief Executive Officer Eric Mendelsohn sa
TG Therapeutics reported third quarter 2026 revenue of US$259.94 million and net income of US$55.46 million, and raised full year 2026 global revenue guidance to about US$1b. The mix of stronger top line performance and lower earnings per share than a year earlier highlights how higher expenses and investment are shaping TG Therapeutics current profitability profile. This article examines how TG Therapeutics investment narrative is affected by the raised US$1b revenue outlook and the...